Skip to main content

Home

  • About Toolkits

You are here

HIV/AIDS // Microbicides Toolkit
  • Toolkit Sitemap
  • Feedback

CAPRISA 004 Tenofovir Gel Trial

This web page provides an overview of the CAPRISA 004 trial, including a summary of key results and implications for future research. Links to a study backgrounder, fact sheets, and other resources are also provided.

External Links: 
CAPRISA 004 Tenofovir Gel Trial
Year: 
2010
Organization: 
FHI 360, the Centre for AIDS Prevention Research in South Africa
Languages: 
English

Microbicides Toolkit

  • Home
  • About
  • All Resources

Microbicides Toolkit

  • Essential Knowledge
    • The Basics
      • Overview
      • Antiretroviral-Based Prevention
      • Multipurpose Prevention Technologies
    • The Need
    • Status of Microbicide Research
    • Future of Microbicides
    • Useful Links
  • Clinical Research
    • Clinical Research Results
      • Dapivirine ring
      • Tenofovir gel
      • Tenofovir gel (formulated for rectal use)
    • Current and Planned Trials
    • Research Process
      • Research Ethics
      • Community Engagement
      • Safety
      • Adherence
      • Drug Resistance
      • Standards of HIV Prevention and Care
  • Implementation Research
    • Preparing for Introduction
    • Acceptability and Affordability
    • Impact and Cost-effectiveness
    • Access and Delivery
  • Policy and Guidelines
    • Key Resources
    • Guidelines
  • Advocacy and Communication
    • Advocacy
      • Reports
      • Fact Sheets
      • Films
      • Toolkits
      • Additional Resources
    • Communication
  • Training
  • Country Experiences
    • Clinical Research
    • Implementation Research

Search This Toolkit

  • Print Toolkit

This website is made possible by the support of the American People through the United States Agency for International Development (USAID) under the Knowledge SUCCESS (Strengthening Use, Capacity, Collaboration, Exchange, Synthesis, and Sharing) Project. Knowledge SUCCESS is supported by USAID’s Bureau for Global Health, Office of Population and Reproductive Health and led by the Johns Hopkins Center for Communication Programs (CCP) in partnership with Amref Health Africa, The Busara Center for Behavioral Economics (Busara), and FHI 360. The contents of this website are the sole responsibility of CCP. The information provided on this website does not necessarily reflect the views of USAID, the United States Government, or the Johns Hopkins University. Read our full Security, Privacy, and Copyright Policies.

USAID